Clinical Efficacy of Cefditoren Pivoxil for Exacerbation of Chronic Obstructive Pulmonary Disease
Phase of Trial: Phase IV
Latest Information Update: 10 Jul 2019
At a glance
- Drugs Cefditoren pivoxil (Primary)
- Indications Bacterial infections; Chronic obstructive pulmonary disease; Respiratory tract infections
- Focus Therapeutic Use
- 09 Jul 2019 Status changed from active, no longer recruiting to completed.
- 23 May 2017 Status changed from recruiting to active, no longer recruiting.
- 27 Feb 2015 Planned End Date changed from 31 Jul 2014 to 30 Apr 2017 as per University Hospital Medical Information Network - Japan record.